Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Artificial Intelligence Breast Cancer Screening Project Wins Government Funding for NHS Trial
UK researchers have secured government funding to study the use of artificial intelligence (AI) for breast cancer screening in […]
The Chinese University of Hong Kong and ConsenSys Announce the Medoxie COVID-19 Digital Health Passport
The Chinese University of Hong Kong (CUHK) along with ConsenSys, the leading Ethereum software company, […]
Judopay Partners with MedPoint to Enable Socially-distanced Payment and Collection of Prescriptions
Judopay, the leading mobile-centric and fully cloud based payments provider, today announced its partnership with MedPoint, […]
Kesimpta® (Ofatumumab) Data Show Long-term Preservation of IgG/IgM Levels and no Increased Risk of Serious Infections in People Living with Multiple Sclerosis
Today, Novartis disclosed new data showing mean IgG and IgM levels remain unchanged in adults […]
Livi Becomes First Digital Healthcare Provider Rated Outstanding by CQC
Livi today announced it has become the first digital healthcare provider in England to be […]
THREAD DESIGN Launch Will Maximize Effectiveness of Decentralized Clinical Trials (DCT)
THREAD, a technology and service provider enabling decentralized clinical trials (“DCT”), today announced the launch […]
Remote Healthcare Market Size Worth $23.9B by 2028
The global remote healthcare market size is expected to reach USD 23.9 billion by 2028, according to a new report […]
Fujifilm Launches Systems Integration Platform Specifically Designed for Endoscopy Suites
FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic and enterprise imaging and integration solutions, today […]
Implantable Brain Device Relieves Pain in Early Study
A computerized brain implant effectively relieves short-term and chronic pain in rodents, a new study […]
EVERSANA ™ Expands Medical Information and Integrated Compliance Services Across Europe
EVERSANA ™, the pioneer of next generation commercial services to the global life sciences industry, today […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more